Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase

被引:19
|
作者
Li, Q [1 ]
Kasten-Jolly, J
Yen, Y
Freed, BM
机构
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Surg, Albany, NY 12208 USA
[3] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA 91010 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Clin Immunol & Histocompatibil Lab, Dept Med, Denver, CO 80262 USA
关键词
D O I
10.1006/taap.1998.8394
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydroquinone (HQ) is a benzene derivative that is found in large quantities in cigarette tar as a result of the pyrolysis of tobacco flavinoids, HQ is a potent inhibitor of T cell proliferation causing an immediate and complete cessation of DNA synthesis in IL-2-dependent human T lymphoblasts and Jurkat T cells without loss of cell viability. Previous studies from our laboratory demonstrated that the antiproliferative effects of HQ could be partially reversed by the addition of deoxyribonucleosides, but not by the corresponding ribonucleosides, suggesting that HQ might inhibit ribonucleotide reductase, In the present study, the molecular mechanism behind this observation was further investigated. Jurkat T cells were stably transfected with a pMEP4 expression vector containing the gene for the M2 subunit of ribonucleotide reductase under transcriptional control of the human metallothionein IIA promoter. M2-transfected Jurkat T cells exhibited a greater than three-fold increase in resistance to HQ compared to untransfected cells or cells transfected with the M2 gene in the reverse orientation. HQ resistance was associated with an increased level of M2 protein detected by Western blot, These results suggest that the benzene derivative inhibits lymphocyte proliferation by inhibiting ribonucleotide reductase. (C) 1998 Academic Press.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 50 条
  • [1] Ribonucleotide reductase M2 subunit as novel target for liposarcoma
    Geha, Rula C.
    Wu, Vicotria
    DeCarolis, Penelope
    O'Connor, Rachael
    Chen, JinHong
    Schwartz, Gary
    Singer, Samuel
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : S86 - S86
  • [2] Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells via HuR-mediated mRNA stabilization
    Zhang, Jing
    Wu, Qiong
    Xie, Yifei
    Li, Feng
    Wei, Huifang
    Jiang, Yanan
    Qiao, Yan
    Li, Yinhua
    Sun, Yanan
    Huang, Han
    Ge, Mengmeng
    Zhao, Dengyun
    Dong, Zigang
    Liu, Kangdong
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (10) : 4329 - 4344
  • [3] Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma
    Zou, Yun
    Zhou, Juan
    Xu, Bin
    Li, Wenzhi
    Wang, Zhong
    ONCOTARGETS AND THERAPY, 2019, 12 : 3267 - 3275
  • [4] Ribonucleotide reductase M2 subunit switching in hepatoblastoma drug resistance and relapse
    Brown, Anthony Ray
    Indersie, Emilie
    Porter, Shaina
    Hansen, Baranda
    Fan, Li
    Li, Liyuan
    Tian, Cheng
    Tan, Haiyan
    Miller, Shondra
    Peng, Junmin
    Cairo, Stefano
    Zhu, Liqin
    CANCER RESEARCH, 2022, 82 (12)
  • [5] PHYSICAL CHARACTERISTICS OF THE M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE FROM CALF THYMUS
    MATTALIANO, RJ
    SLOAN, AM
    PLUMER, ER
    KLIPPENSTEIN, GL
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 892 - 892
  • [6] Activation of ribonucleotide reductase regulatory subunit M2 promotes the progression of ATRT
    Giang, Le H.
    Wong, Taitong
    Chang, Chechang
    CANCER SCIENCE, 2024, 115 : 281 - 281
  • [7] Ribonucleotide Reductase Subunit M2 Levels Affect Resistance to Gemcitabine In Vitro
    Melling, J.
    Shaw, E.
    Dajani, K.
    Lane, B.
    Bauer, A.
    Hoheisel, J.
    Neoptolemos, J.
    Greenhalf, W.
    Ghaneh, P.
    PANCREAS, 2012, 41 (08) : 1384 - 1384
  • [8] Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma
    Han, Ping
    Lin, Zhi-Rui
    Xu, Li-Hua
    Zhong, Qian
    Zhu, Xiao-Fen
    Liang, Fa-Ya
    Cai, Qian
    Huang, Xiao-Ming
    Zeng, Mu-Sheng
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 401 - 409
  • [9] Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Mazzu, Ying Z.
    Armenia, Joshua
    Nandakumar, Subhiksha
    Chakraborty, Goutam
    Yoshikawa, Yuki
    Jehane, Lina E.
    Lee, Gwo-Shu Mary
    Atiq, Mohammad
    Khan, Nabeela
    Schultz, Nikolaus
    Kantoff, Philip W.
    MOLECULAR ONCOLOGY, 2020, 14 (08) : 1881 - 1897
  • [10] A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer
    Wang, Yong
    Chen, Rong
    Zhang, Jing
    Zeng, Peng
    PLOS ONE, 2024, 19 (04):